HOLX - Hologic: Prospects For Growth As Headwinds Disappear
2024-02-11 10:54:53 ET
Summary
- Hologic aims to elevate women's health globally, with diagnostics making up nearly half of sales.
- The company experienced a boom in COVID diagnostics sales in 2020 and 2021, creating headwinds thereafter, yet this is set to end in 2024.
- Amidst a gradual reduction in valuations and improved balance sheet strength, appeal is getting evident here.
Shares of Hologic ( HOLX ) have been trading relatively stagnant in recent years, while the underlying business has seen quite some volatility since the outset of the pandemic. This creates quite an interesting set-up....
Hologic: Prospects For Growth As Headwinds Disappear